The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1302
https://www.valueinhealthjournal.com/article/S1098-3015(13)03207-5/fulltext
Title : The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03207-5&doi=10.1016/j.jval.2013.08.1302
First page : A529
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1150
Categories :
Tags :
Regions :
ViH Article Tags :